Aldeyra Therapeutics Inc (NASDAQ:ALDX) shares, rose in value on Thursday, April 04, with the stock price up by 12.89% to the previous day’s close as strong demand from buyers drove the stock to $4.68.
Actively observing the price movement in the recent trading, the stock is buoying the session at $4.15. The value of beta (5-year monthly) is 1.52. Referring to stock’s 52-week performance, its high was $11.97, and the low was $1.42. On the whole, ALDX has fluctuated by 19.21% over the past month.
With the market capitalization of Aldeyra Therapeutics Inc currently standing at about $275.95 million, investors are eagerly awaiting this quarter’s results, scheduled for May 02, 2024 – May 06, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.11, which is expected to increase to -$0.1 for fiscal year -$0.12 and then to about -$0.41 by fiscal year 2025. Data indicates that the EPS growth is expected to be 81.20% in 2025, while the next year’s EPS growth is forecast to be -241.70%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ALDX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ALDX currently trading nearly 47.34% and 41.09% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 78.35, while the 7-day volatility ratio is showing 11.35% which for the 30-day chart, stands at 7.23%. Furthermore, Aldeyra Therapeutics Inc (ALDX)’s beta value is 1.49, and its average true range (ATR) is 0.28.
A comparison of Aldeyra Therapeutics Inc (ALDX) with its peers suggests the former has fared considerably weaker in the market. ALDX showed an intraday change of 12.89% in today’s session so far, and over the past year, it shrunk by -52.34%%.
Data on historical trading for Aldeyra Therapeutics Inc (NASDAQ:ALDX) indicates that the trading volumes over the past 10 days have averaged 0.62 million and over the past 3 months, they’ve averaged 524.80K. According to company’s latest data on outstanding shares, there are 59.20 million shares outstanding.
Nearly 3.98% of Aldeyra Therapeutics Inc’s shares belong to company insiders and institutional investors own 59.51% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.83 million shares as on Mar 15, 2024, resulting in a short ratio of 3.26. According to the data, the short interest in Aldeyra Therapeutics Inc (ALDX) stood at 3.10% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 1.93 million. The stock has risen by 33.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALDX stock heading into the next quarter.
